Tax Court rules on medical necessities
Since the 1990 enactment of Sec. 213(d)(9), which stipulates that expenses for cosmetic surgery are not deductible, the IRS has subjected medical expense deductions to increased scrutiny. Nonetheless, over the past decade the definition of deductible medical expenses has expanded to include breast r...
Saved in:
Published in | The Tax Adviser Vol. 41; no. 10; p. 698 |
---|---|
Main Author | |
Format | Magazine Article Trade Publication Article |
Language | English |
Published |
New York
American Institute of CPA's
01.10.2010
American Institute of Certified Public Accountants |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Since the 1990 enactment of Sec. 213(d)(9), which stipulates that expenses for cosmetic surgery are not deductible, the IRS has subjected medical expense deductions to increased scrutiny. Nonetheless, over the past decade the definition of deductible medical expenses has expanded to include breast reconstruction subsequent to mastectomy (cancer); laser eye surgery (myopia); nonprescription medical supplies; and expenses for obtaining an egg donor (infertility treatment). In O'Donnabhain the Tax Court has expanded the list of deductible medical expenses to include hormone therapy and sex reassignment expenses for the treatment of gender identity disorder (GID). On her 2001 tax return, Rhiannon G. O'Donnabhain claimed itemized medical deductions for GID treatment. The IRS denied the deductions in January 2006 via a statutory notice of deficiency, and the taxpayer petitioned the Tax Court in March 2006. Nearly four years later, on February 2, 2010, the Tax Court ruled in favor of O'Donnabhain. The 90-day appeal period passed without an appeal by the IRS. |
---|---|
ISSN: | 0039-9957 |